Recombinant Bevacizumab anticorps

N° du produit ABIN7482170

L’anticorps Souris Monoclonal anti-Bevacizumab a été validé pour . Il convient pour détecter Bevacizumab dans des échantillons de Humain.

Aperçu rapide pour Recombinant Bevacizumab anticorps (ABIN7482170)

Antigène: Bevacizumab

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Bevacizumab est non-conjugé

Classe de qualité: MALS verified

Clone: AY10

Détail du produit anti-Bevacizumab anticorps

Fonction: Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)

Attributs du produit: Anti-idiotypic Antibodies

Immunogène: Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Stock: -20 °C

Détails sur Bevacizumab

Antigène: Bevacizumab

Classe de substances: Antibody

Sujet: A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.